Did you miss the live Virtual Glycan Day in June? All presentations are now available to watch on-demand at your leisure.
Watch presentations from Glycan Experts across the industry!
As the world of therapeutics changes rapidly, so do the challenges we face in glycan analysis. Innovative modalities are bringing new obstacles for experts to navigate with never required before CQA’s to analyse. We have brough together some of the most influential figures in the glycan world to discuss innovations, challenges and solutions around glycan analysis.
Key learning objectives:
Yongjing Xie
Post-doctoral researcher, NIBRT, Ireland
Quantitative N-glycosylation profiling of SARS-CoV-2 serum and spike proteins with high-throughput and high-sensitivity InstantPC platform
Ganesh Pravin Gharat MS.c
Manager Process Analytics-R&D, Intas Pharmaceuticals Ltd
Sialic Acid: Recent Trends and Advancements
Monique van Scherpenzeel
CEO & Founder, GlycoMScan B.V
LC/MS analyses from Mono- to Oligosaccharides challenging bio-analyses and characterizations
Tea Petrović
Laboratory Analyst; Ph.D student, Genos Ltd, Croatia
Immunoglobulin G N-glycan analysis in asymptomatic and mild COVID-19
Gordan Lauc
Professor at the University of Zagreb and Founder of Genos Glycoscience Research Laboratory, Genos Ltd, Croatia
The Human Glycome Project - What did we learn from the first 150,000 human glycomes?
Panel discussion
Speakers panel discussion with Yongjing Xie, Ganesh Pravin Gharat, Monique van Scherpenzeel with host Beth Morgan, Head of BioPharma & Chemistries at Agilent Technologies
For Research Use Only. Not for use in diagnostic procedures.
RA44727.6943171296